Confronting multidrug-resistant Acinetobacter baumannii: a review
Ioannis K Neonakis1, Demetrios A Spandidos, Efthimia Petinaki
1Department of Microbiology, Medical School, University of Thessaly, Larissa, Greece. ineonakis@gmail.com
Abstract:
Multidrug-resistant Acinetobacter baumannii (MDR-AB) infections are difficult to treat owing to the extremely limited armamentarium. The present review reports all available treatment options against MDR-AB, including single molecules, combination schemes, and alternative modes of antimicrobial administration. Additionally, a group of recently reported peptides with anti-MDR-AB activity is described.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Acute Pyelonephritis II: Diagnostic Studies and Management
Antimicrobial Effectiveness

